Xiamen Amoytop Biotech Co.Ltd(688278)
Prior approval opinions of independent directors on the renewal of the accounting firm. As an independent director of Xiamen Amoytop Biotech Co.Ltd(688278) (hereinafter referred to as the “company”), based on the independent and objective position, in accordance with the relevant provisions of the company law, the securities law, the Listing Rules of science and innovation board of Shanghai Stock Exchange and the articles of association, Express the following prior approval opinions on the company’s plan to continue to employ Rongcheng Certified Public Accountants (special general partnership) as the audit institution in 2022:
In combination with the company’s audit in 2021 and the verification of the professional qualifications and resumes of project members of Rongcheng Certified Public Accountants (special general partnership), he was diligent and responsible during his tenure as the company’s audit institution in 2021, and was able to follow the independent, objective and fair professional standards in the process of practice, and the report issued fairly reflected the company’s financial status and operating results, Agree to submit the proposal of renewing the appointment of the accounting firm to the board of directors for deliberation.
(there is no text on this page, which is the signature page of Xiamen Amoytop Biotech Co.Ltd(688278) independent directors’ prior approval opinions on the renewal of accounting firm)
Signature: Signature:
Name: Jiang Xiaohui Name: Zhou Kefu
Signature: Name: Liu Qi
March 30, 2022
